Navigation Links
GPhA Statement on the Introduction of the Bipartisan Biogenerics Consensus Bill: 'Promoting Innovation and Access to Life-Saving Medicine Act'
Date:3/11/2009

fordable biogenerics. They've heard that the FDA scientists want the authority and flexibility to determine how to best ensure safety and efficacy. And they've heard that significant cost savings will result from bringing biogenerics to consumers.

"This bipartisan bill recognizes our health care system's successful experience with generic medicines for the past 25 years. The market exclusivity provisions in Hatch-Waxman have clearly demonstrated that we can achieve the much-needed balance between pharmaceutical competition and innovation for the benefit of consumers, payors and state and federal governments. We've done it before with generics and we can do it again with biogenerics.

"Now, it's time for action. Now, more than ever, it's time to put patients first.

"During these difficult economic times, there must be increased urgency to support solutions that strengthen health care while reducing costs. 'The Promoting Innovation and Access to Life-Saving Medicine Act' is the right solution for high quality care at affordable costs."

GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic drug industry. Generics represent 69% of the total prescriptions dispensed in the United States, but only 16% of all dollars spent on prescription drugs. For more information on biogenerics, please log on to www.gphaonline.org.


'/>"/>
SOURCE Generic Pharmaceutical Association (GPhA)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. CV Therapeutics Statement on Unsolicited Proposal From Astellas
2. Sinovac Releases Statement on Healive Vaccine Suspension
3. Helix BioPharma Files Form 20-F Registration Statement With the U.S. Securities and Exchange Commission
4. Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2)
5. Resverlogix Issues a Management Statement
6. A Statement From Larry Corey, MD, of the HIV Vaccine Trials Network Regarding the New HIV Infection Statistics Released Today by the Centers for Disease Control
7. Jazz Pharmaceuticals Files Form S-3 Registration Statements
8. Catalyst Pharmaceutical Partners, Inc. Files Form S-3 Shelf Registration Statement
9. Statement from Lighthouse International About the Study on Gene Therapy Concerning Lebers Congenital Amaurosis
10. Occlutech Clarifies Statement Regarding Favourable Opinion Obtained From AIPPI With Regard to Patents Held by AGA Medical
11. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade hypothermic storage and cryopreservation freeze ... and tissues  ("BioLife" or the "Company"), today announced that it ... 4, 2015 (the "Annual Meeting"). Because the expected ...
(Date:12/24/2014)... 23, 2014 Earlier this year in a ... of the Adult Stem Cell Technology Center, LLC ( ASCTC ... unique property of adult tissue stem cells. His title ... Important for the Future,” embodied the essence of his message ...
(Date:12/24/2014)... According to Ross Selinger, President of Selinger ... the national office market continues to be strong, driven by ... by the third quarter’s surprising 3.9% GDP, unemployment decreasing to ... have held inflation down and the Fed is keeping interest ...
(Date:12/24/2014)... 2014 The report expects global cell isolation ... also provides a carefully analyzed data about the vital drivers, ... Full Copy of Report @ http://bit.ly/1yUxy0T , According ... keep witnessing growth at an impressive CAGR during near future. ...
Breaking Biology Technology:BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3
... conjunction with,CorVel Corporation,s (Nasdaq: CRVL ) fiscal year earnings release, CorVel,will be ... June 10th at 11:30 am Eastern Time., Event: ... Starck, President and CEO ... 11:30 am Eastern Time, Tuesday, June 10th, 2008, Login: ...
... Xceed,s Dr. David Englert and Dr. Zhe Zhang of Children,s Hospital of, ... ... 21st, WELLESLEY, ... easy-to-use gene-expression analysis,systems, announced that the company will feature its Ziplex Automated,Gene-Expression ...
... China, May 16 /Xinhua-PRNewswire-FirstCall/ --,China Pharma Holdings, ... develops, manufactures, and markets generic and brand,bio-pharmaceutical ... donated 2,million RMB (approximately US$285,714) worth of ... medicines to help disaster relief in,China after ...
Cached Biology Technology:CorVel Corporation Announces Earnings Release Webcast 2Xceed Molecular Features Ziplex(R) Automated Gene-Expression System at the Biomarker World Congress, Booth 16 2China Pharma Holdings, Inc. Donates Medicine for Sichuan Earthquake Relief 2
(Date:12/17/2014)... 2014  HITLAB SM announced today its completion of ... adherence to current U.S. Food and Drug Administration (FDA) ... device and smart phone application trials utilizing the highest ... "HITLAB is determined to improve global healthcare access, quality, ...
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) has ... Market 2015-2019" report to their offering. ... is a technology used for the identification of individuals. ... a person such as nose, jaw edges, mouth, and ...
(Date:12/11/2014)... 10, 2014  Data Sciences International (DSI), the global ... new series of digital telemetry implants to meet ... series, part of the PhysioTel™ Digital platform, was ... physiologic data when incorporating functional endpoints into repeat-dose ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2
... Italian research team, publishing in the current issue of ... on-line without charge at http://www.ingentaconnect.com/content/cog/ct , has found ... play a role in the treatment of lung diseases, ... tuberculosis, chemical exposure, radiation or pathogens. These diseases can ...
... Muscular Atrophy is the second-leading cause of infant mortality in ... at Iowa State University,s College of Veterinary Medicine, would like ... even slide off the list altogether. , Most Spinal Muscular ... mutated or deleted gene called Survival Motor Neuron 1 (SMN1) ...
... at Penn State University, in collaboration with institutes in the ... long-sought structure of a layer of C60 carbon buckyballs ... help in the design of carbon nanostructure-based electronics are reported ... July 27th issue of APS,s on-line journal Physics ...
Cached Biology News:Placenta-derived stem cells may help sufferers of lung diseases 2ISU researchers find possible treatment for spinal muscular atrophy 2
EnzChek Ultra Xylanase Assay Kit *500 assays*...
Anti-DAP-1, Rabbit Monoclonal Immunogen: KLH-conjugated synthetic peptide corresponding to the C-terminal region of human DAP-1. Molecular Weight: 11 kDa Quality Assurance: Routinely eval...
Wnt-1 (G-19)...
Human Osteocalcin (1-22) mature form. Also reacts with Osteocalcin (1-44) and Osteocalcin (1-49). No reactivity with Bone sialoprotein....
Biology Products: